Beisol Pharma Meerle
ActiveBeisol Pharma Meerle has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-72k) and a net result of €12k. Equity is shrinking by ~54.9% per year across the filed fiscal years. Its solvency ranks better than 13% of 1511 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Checked score
Score 2025
37
/ 100
Weak
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability60▼-7
Solvency0=
Growth38▲+16
Track record100
Bankruptcy probability, 12 months
1.1%
Low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.66 against 0.64 in 2024; short-term debt: 152.5% and cash: 0.1% of total assets), and equity is negative.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 77
Relative position
BE, all sectors
reference
Sector 77
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-52.5%
Return on assets
9%
Age of the figures
18 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 13% of 1511 sector peers (2025).
NBB · sector comparisonPosition among 1511 sector peers
Solvency
better than 13%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 21-10-2025, 10 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
10 d early
2024
16 d early
2023
8 d early
2022
14 d early
2021
31 d early
2020
15 d late
2019
23 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven monthsPosition in the running window
31-03-2026 close20-09-2026 today31-10-2026 deadline
Financials · fiscal year 2025, micro schema
Turnover
€20k▼ 50.0%
2024 · €41k
2019: €76k
2020: €68k
2021: €38k
2022: €39k
2023: €46k
2024: €41k
2019 → 2025
EBIT margin
60.6%▲ 116.1pp
2024 · -55.5%
2019: 17.0%
2020: 6.3%
2021: -65.7%
2022: -58.8%
2023: -46.4%
2024: -55.5%
2019 → 2025
Net result
€12k
2024 · €-23k
2019: €7k
2020: €-2k
2021: €-29k
2022: €-24k
2023: €-25k
2024: €-23k
2019 → 2025
Working capital
€-72k▲ 14.6%
2024 · €-85k
2019: €-194k
2020: €-172k
2021: €-175k
2022: €-145k
2023: €-115k
2024: €-85k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€38k-€39k▲ 1.3%€46k▲ 19.1%€41k▼ 11.1%€20k▼ 50.0%
Equity€-13k-€-37k▼ 176%€-62k▼ 66.2%€-85k▼ 37.1%€-72k▲ 14.6%
Operating result€-25k-€-23k▲ 9.4%€-21k▲ 6.0%€-23k▼ 6.3%€12k
Net result€-29k-€-24k▲ 18.7%€-25k▼ 3.8%€-23k▲ 6.9%€12k
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €12k after a loss of €23k in 2024, the highest result in the available series.
Key figures and ratios
Solvency
-52.5%▲
2024 · -57.3%
Current ratio
0.66▲
2024 · 0.64
Quick ratio
0.15▼
2024 · 0.18
Debt / equity
-2.90▼
2024 · -2.74
ROA
9.0%▲
2024 · -15.5%
Debt
€210k▼
2024 · €232k
Debt ≤ 1 year
€210k▼
2024 · €232k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€148k€137k▼
Intangible fixed assets21€0-
Tangible fixed assets22/27€0-
Current assets29/58€148k€137k▼
Stocks and contracts in progress3€107k€107k=
Stocks30/36€107k€107k=
Amounts receivable within one year40/41€41k€31k▼
Trade receivables40€41k€31k▼
Cash at bank and in hand54/58€8€180▲
Equity and liabilities
Total equity and liabilities10/49€148k€137k▼
Equity10/15€-85k€-72k▲
Contributions10/11€6k€6k=
Capital10€6k€6k=
Issued capital100€19k€19k=
Uncalled capital101€12k€12k=
Reserves13€11k€11k=
Non-distributable reserves130/1€555€555=
Legal reserve130€555€555=
Distributable reserves133€11k€11k=
Profit (loss) carried forward14€-102k€-90k▲
Amounts payable17/49€232k€210k▼
Amounts payable within one year42/48€232k€210k▼
Trade debts44€6k€11k▲
Suppliers440/4€6k€11k▲
Taxes, remuneration and social security45€69€1k▲
Taxes450/3€69€1k▲
Other amounts payable47/48€226k€198k▼
Income statement
Code20242025
Turnover70€41k€20k▼
Goods, raw materials, services and sundry goods60/61€10k€8k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€54k-
Other operating charges640/8€384€387▲
Gross operating margin9900€31k€13k▼
Operating profit (loss)9901€-23k€12k▲
Financial charges65/66B€154€30▼
Recurring financial charges65€154€30▼
Profit (loss) for the period before taxes9903€-23k€12k▲
Profit (loss) for the period9904€-23k€12k▲
Profit (loss) for the period to be appropriated9905€-23k€12k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-102k€-90k▲
Profit (loss) brought forward from the previous period14P€-79k€-102k▼
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
21-10
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
31-03
Financial
Back to profitnet €12k
Net result €12k after 5 loss-making years.
2024
15-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2023
23-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2022
17-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2021
30-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
31-03
Financial
Weakest financial yearnet €-29k
Net result drops to €-29k, the lowest in the series; recovery starts the following year.
2020
15-11
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 15 days late
2019
08-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
10-09
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
06-11
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 6 days late
2016
13-09
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Lubbeek · 1 establishment unit since 2014
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Staatsbaan(LUB) 1873210 LubbeekGround area
1,002 m²
Building footprint
263 m²
Volume, LiDAR
2,293 m³
Parcel 24066H0017/00G004, Flanders · tallest building 12.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
beisol pharma meerle
since 20142.226.735.067
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24066H0017/00G004 | Flanders | 1,002 m² | 1 · 263 m² | 12.5 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PRISMA Patents & Research
BE 0766.673.944
Oud-Heverlee · Eq €15k
NUVOLA FRANCHISE
BE 0801.201.687
Aalst · Eq €14k
PETRAL
BE 0777.892.785
Brussel · Eq €14k
WORLDOFINVENTIONS
BE 1016.271.176
Kortrijk · Eq €19k
Laurette Cosmetics
BE 0751.842.545
Lennik · Eq €12k
Of 421 companies in sector 77400 we hold annual accounts for 152. 80 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded22-01-2014
Fiscal year end31-03
Activities, NACEBEL
77400Rental and leasing activities
Sources
Crossroads Bank for EnterprisesNational Bank · 11 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
3 entriesE-mail:theo@craynwinkel.be
Phone:016622141
Fax:016620609